The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

Mergers and acquisitions (M&As) in the biopharmaceutical industry surged 101% in total deal value in first-quarter 2025 from ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

Cidara Therapeutics, a San Diego biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) ...

The head of the World Health Organization has issued a stark warning that sudden cuts to global health budgets, including by ...

US biotech major Amgen (Nasdaq AMGN) late Thursday announced financial results for the first quarter of 2025, revealing that ...

The US Department of Health and Human Services has announced a sweeping change to the way new vaccines are evaluated, saying ...

Shares in Kronos Bio, a US biotech that has been developing small molecule therapeutics to address cancers and other diseases ...

Clinical-stage biopharma company Satsuma Pharmaceuticals and its corporate parent, Shin Nippon Biomedical (TYO: 2395), ...